Impact of Structural Differences on thein VitroGlucuronidation Kinetics of Potentially Dopaminergic Hydroxy‐2‐Aminotetralins and Naphthoxazines Using Rat and Human Liver Microsomes
- 25 March 1991
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 68 (3) , 215-219
- https://doi.org/10.1111/j.1600-0773.1991.tb01226.x
Abstract
Thein vitroglucuronidation of seven monohydroxy‐2‐aminotetralins and two naphthoxazines has been determined using human and rat liver microsomes. All these compounds stimulate the D2dopamine receptor. The influence of the position of the phenolic hydroxyl group was studied with rat microsomes in monohydroxy‐2‐(N,N‐dipropylamino)‐tretralins. The highest activity and intrinsic clearance was found for 7‐OH‐DPAT, but the latter values for 5‐OH‐DPAT and 6‐OH‐DPAT were much lower by a factor of 9 and 30, respectively. The 8‐OH‐isomer was not glucuronidated at all. Substitution of a propyl side chain by a thienylethyl‐, or phenylethyl side chain, in 5‐hydroxy‐DPAT, or in (+)‐4‐propyl‐9‐hydroxyhexahydronaphthoxazine (PHNO, N‐0500), showed a large increase of the UDPGT affinity and intrinsic clearance especially for N‐0437. It also resulted for N‐0437 in a much higher affinity towards the dopaminergic D2 receptor. Although the glucuronidation activity of human microsomes was found to be considerably lower than that of rat microsomes, the latter phenomenon was clearly visible with human microsomes as well. These findings may have serious implications for the ability of these drugs to adequately reach the brain.Keywords
This publication has 19 references indexed in Scilit:
- The metabolic fate of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in rats after intravenous and oral administration II. Isolation and identification of metabolitesXenobiotica, 1990
- The metabolic fate of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in rats after intravenous and oral administration I. Disposition and metabolic profilingXenobiotica, 1990
- Stereoselective reversal of MPTP-induced parkinsonism in the marmoset after dermal application of N-0437European Journal of Pharmacology, 1989
- Udp-Glucuronosyltrans-Ferases in the Metabolic Disposition of XenobioticsDrug Metabolism Reviews, 1989
- The antiparkinsonian actions and pharmacokinetics of transdermal (+)‐4‐Propyl‐9‐hydroxynaphthoxazine (+ PHNO): Preliminary resultsMovement Disorders, 1989
- Glucuronidation of the Enantiomers of E‐10‐Hydroxynortriptyline in Human and Rat Liver MicrosomesBasic & Clinical Pharmacology & Toxicology, 1987
- In vitro evaluation of glucuronidation of monohydroxylated aglycones related to quantum chemically-calculated parametersEuropean Journal of Medicinal Chemistry, 1987
- PHNO, a novel dopamine agonist, in animal models of parkinsonismMovement Disorders, 1987
- UDPglucosyltransferase and Its Kinetic Fluorimetric AssayEuropean Journal of Biochemistry, 1983
- Synthesis and pharmacology of some 2-aminotetralins. Dopamine receptor agonistsJournal of Medicinal Chemistry, 1975